Eric Lefkofsky’s Tempus Raises More Funding to expand its Research Operations

Tempus is a Chicago-based cancer research company co-founded by Eric Lefkofsky in 2015. Its main area of focus is genomic-testing and cancer-fighting data analytics. Since its founding, Tempus has been at the forefront of finding solutions in the field of cancer treatment and management. Recently Tempus raised $110 million in funding. This fundi…